Journal ArticleCancer Biol Ther · December 31, 2024
Neuroblastoma is the most frequent extracranial pediatric tumor and leads to 15% of all cancer-related deaths in children. Tumor relapse and therapy resistance in neuroblastoma are driven by phenotypic plasticity and heterogeneity between noradrenergic (NO ...
Full textLink to itemCite
Journal ArticleBMC Cancer · October 17, 2024
PURPOSE: Loddo et al. (Br J Cancer 100:959-70, 2009) established the prognostic significance of cell cycle markers and "Cell-Cycle Phenotypes" in breast carcinoma. This study aims to 1) identify prognostic cell-cycle markers in sarcoma, and 2) assess the p ...
Full textLink to itemCite
Journal ArticleBMC Musculoskelet Disord · August 31, 2024
BACKGROUND: Orthopedic procedures often require removing bone or pathological tissue, with traditional methods involving instruments like curettes and rongeurs. However, these methods can be time-consuming and lead to increased blood loss. To mitigate thes ...
Full textLink to itemCite
Journal ArticleiScience · July 19, 2024
Intra-tumoral phenotypic heterogeneity promotes tumor relapse and therapeutic resistance and remains an unsolved clinical challenge. Decoding the interconnections among different biological axes of plasticity is crucial to understand the molecular origins ...
Full textCite
Journal ArticleEnviron Sci Technol · June 18, 2024
Microplastics are routinely ingested and inhaled by humans and other organisms. Despite the frequency of plastic exposure, little is known about its health consequences. Of particular concern are plastic additives─chemical compounds that are intentionally ...
Full textLink to itemCite
Journal ArticleSarcoma · 2024
PURPOSE: Recently, the association between ATRX and a more aggressive sarcoma phenotype has been shown. We performed a retrospective study of sarcomas from an individual institution to evaluate ATRX as a prognosticator in soft tissue sarcoma. Experimental ...
Full textLink to itemCite
Chapter · January 1, 2024
Chapter 1 introduces cancer as a speciation event that is inexorably linked to multicellularity and marked by a return to unicellularity. Although each cancer arises as an independent speciation event, common ecological features drive convergent evolution ...
Full textCite
Chapter · January 1, 2024
Cancer is a result of the breakdown in processes governing multicellularity, leading to a population of cells that no longer abide by the cues of their multicellular context and begin to act as a population of unicellular organisms within the body. This ch ...
Full textCite
Chapter · January 1, 2024
This chapter summarizes the main points of the prior chapters, discusses the benefits of incorporating ecological and evolutionary perspectives into research and treatment of cancer, and highlights gaps in our knowledge. In particular, the chapter discusse ...
Full textCite
Book · January 1, 2024
New cancer cells exist in an ever-changing “ecology” and are subject to evolutionary pressures just like any species in nature. This edited book explores the following themes: 1) how the dynamics of mutation, epigenetics, and gene expression noise are sour ...
Full textCite
Journal ArticleSemin Cancer Biol · November 2023
Phenotypic plasticity was recently incorporated as a hallmark of cancer. This plasticity can manifest along many interconnected axes, such as stemness and differentiation, drug-sensitive and drug-resistant states, and between epithelial and mesenchymal cel ...
Full textLink to itemCite
Journal ArticleJ Immunother Cancer · September 2023
BACKGROUND: Phenotypic heterogeneity of melanoma cells contributes to drug tolerance, increased metastasis, and immune evasion in patients with progressive disease. Diverse mechanisms have been individually reported to shape extensive intra-tumor and inter ...
Full textLink to itemCite
Journal ArticleJCO Precis Oncol · August 2023
PURPOSE: Men with rising prostate-specific antigen (PSA) after radical prostatectomy (RP) may progress despite radiation and androgen-deprivation therapy (ADT). Tissue-based transcriptomic signatures can identify who may benefit from a more aggressive syst ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · July 3, 2023
ATRX is one of the most frequently altered genes in solid tumors, and mutation is especially frequent in soft tissue sarcomas. However, the role of ATRX in tumor development and response to cancer therapies remains poorly understood. Here, we developed a p ...
Full textLink to itemCite
Journal ArticleAdvances in Cancer Biology - Metastasis · July 1, 2023
Oncoviruses exploit diverse host mechanisms to survive and proliferate. These adaptive strategies overlap with mechanisms employed by malignant cells during their adaptation to dynamic micro-environments and for evasion of immune attack. While the role of ...
Full textCite
Journal ArticlePhysiol Rep · June 2023
While basal metabolic rate (BMR) scales proportionally with body mass (Mb ), it remains unclear whether the relationship differs between mammals from aquatic and terrestrial habitats. We hypothesized that differences in BMR allometry would be reflected in ...
Full textLink to itemCite
Journal ArticleJ Biol Eng · March 2, 2023
BACKGROUND: Epithelial-mesenchymal plasticity (EMP) involves bidirectional transitions between epithelial, mesenchymal and multiple intermediary hybrid epithelial/mesenchymal phenotypes. While the process of epithelial-mesenchymal transition (EMT) and its ...
Full textLink to itemCite
Journal ArticleFrontiers in Marine Science · January 10, 2023
Plastic heterogeneously affects social systems – notably human health and local and global economies. Here we discuss illustrative examples of the benefits and burdens of each stage of the plastic lifecycle (e.g., macroplastic production, consumption, recy ...
Full textCite
Journal ArticleComput Struct Biotechnol J · 2023
Advanced prostate cancer patients initially respond to hormone therapy, be it in the form of androgen deprivation therapy or second-generation hormone therapies, such as abiraterone acetate or enzalutamide. However, most men with prostate cancer eventually ...
Full textLink to itemCite
Journal ArticleFront Mol Biosci · 2023
Despite substantial improvements in the treatment landscape of prostate cancer, the evolution of hormone therapy-resistant and metastatic prostate cancer remains a major cause of cancer-related death globally. The mainstay of treatment for advanced prostat ...
Full textLink to itemCite
Chapter · January 1, 2023
Dolphins and other marine mammals possess unique adaptations that allow them to thrive in aquatic environments. While many physiological and anatomical adaptations play a clear role in marine mammal phenotypes, less is known about how genetic and molecular ...
Full textCite
Journal ArticleFrontiers in Marine Science · November 2, 2022
The global accumulation of plastic waste has reached crisis levels. The diverse and multilayered impacts of plastic on biological health prompts an evaluation of these effects from a One Health perspective, through which the complexity of these processes c ...
Full textCite
Journal ArticleJCI Insight · September 8, 2022
Osteosarcoma (OS) is a lethal disease with few known targeted therapies. Here, we show that decreased ATRX expression is associated with more aggressive tumor cell phenotypes, including increased growth, migration, invasion, and metastasis. These phenotypi ...
Full textLink to itemCite
ConferenceProstate Cancer Prostatic Dis · September 2022
BACKGROUND: Prostate cancer is a clinically and molecularly heterogeneous disease, with highest incidence and mortality among men of African ancestry. To date, prostate cancer patient-derived xenograft (PCPDX) models to study this disease have been difficu ...
Full textOpen AccessLink to itemCite
Journal ArticleMed Oncol · July 4, 2022
We appear to be faced with 'two truths' in cancer-one of major advances and successes and another one of remaining short-comings and significant challenges. Despite decades of research and substantial progress in treating cancer, most patients with metasta ...
Full textLink to itemCite
Journal ArticleGene · May 20, 2022
This study examines Y-chromosome and mtDNA markers in the population of the island of Kiritimati in the context of geographically targeted reference populations from the Pacific. Kiritimati derives its population from the atoll islands of the Gilbert Archi ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · April 2022
BACKGROUND: Men with progressive neuroendocrine or aggressive-variant metastatic prostate cancer (NEPC/AVPC) have a poor prognosis and limited treatment options, and immunotherapy has not been tested in such patients. METHODS: We conducted an open label si ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2022
BACKGROUND: Limited data are available to inform the risk of readmission and short-term mortality in musculoskeletal oncology. The goal of this study was to identify factors independently associated with 30-day readmission and 90-day mortality following su ...
Full textLink to itemCite
Journal ArticleCancer Med · January 2022
INTRODUCTION: Current standard of care for most intermediate and high-grade soft-tissue sarcomas (STS) includes limb-preserving surgical resection with either neoadjuvant radiation therapy (NRT) or adjuvant radiation therapy. To date, there have been a few ...
Full textLink to itemCite
Journal ArticleEvol Med Public Health · 2022
BACKGROUND AND OBJECTIVES: Hepatocellular carcinoma occurs frequently in prosimians, but the cause of these liver cancers in this group is unknown. Characterizing the genetic changes associated with hepatocellular carcinoma in prosimians may point to possi ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2022
Epithelial to mesenchymal transition (EMT) is a well-studied hallmark of epithelial-like cancers that is characterized by loss of epithelial markers and gain of mesenchymal markers. Melanoma, which is derived from melanocytes of the skin, also undergo phen ...
Full textLink to itemCite
Journal ArticleFront Med (Lausanne) · 2022
Colorectal cancer (CRC) is the third most prevalent form of cancer in the United States and results in over 50,000 deaths per year. Treatments for metastatic CRC are limited, and therefore there is an unmet clinical need for more effective therapies. In ou ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2021
BACKGROUND: There are limited data to inform risk of readmission and short-term mortality in musculoskeletal oncology. The goal of this study was to identify factors independently associated with 30-day readmission and 90-day mortality following surgical r ...
Full textLink to itemCite
Journal ArticleProg Biophys Mol Biol · October 2021
Cancer progression has been attributed to somatic changes in single-nucleotide variants, copy-number aberrations, loss of heterozygosity, chromosomal instability, epistatic interactions, and the tumor microenvironment. It is not entirely clear which of the ...
Full textLink to itemCite
Journal ArticleCancers · October 2021
Epithelial-Mesenchymal Plasticity (EMP) refers to reversible dynamic processes where cells can transition from epithelial to mesenchymal (EMT) or from mesenchymal to epithelial (MET) phenotypes. Both these processes are modulated by multiple transcription ...
Full textCite
Journal ArticleJBJS Case Connect · May 17, 2021
CASE: A 15-year-old boy with chondroblastoma of the right hemipelvis presented with significant periacetabular bone destruction. Neoadjuvant denosumab treatment facilitated initial joint preserving surgery. Unfortunately, he experienced 2 local recurrences ...
Full textLink to itemCite
Journal ArticleFront Ecol Evol · April 2021
Ecological fitness is the ability of individuals in a population to survive and reproduce. Individuals with increased fitness are better equipped to withstand the selective pressures of their environments. This paradigm pertains to all organismal life as w ...
Full textLink to itemCite
Journal ArticleBiomark Res · February 18, 2021
BACKGROUND: A subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of immune checkpo ...
Full textLink to itemCite
Journal ArticleRadiat Res · February 1, 2021
Novel synthetic compounds, known as manganese porphyrins (MnPs), have been designed to shift the redox status of both normal cells and cancer cells. When MnPs are coupled with cancer therapies, such as radiation, they have been shown to sensitize tumor cel ...
Full textLink to itemCite
Journal ArticleFrontiers in Marine Science · January 21, 2021
Marine ecosystems contain over 80% of the world’s biodiversity, and many of these organisms have evolved unique adaptations enabling survival in diverse and challenging environments. The biodiversity within the world’s oceans is a virtually untapped resour ...
Full textCite
Journal Article · 2021
Ischemic events, such as ischemic heart disease and ischemic stroke, are the number one cause of death globally. Ischemia prevents blood, carrying essential nutrients and oxygen, from reaching tissues and organ systems, leading to cell and tissue death, an ...
Full textCite
Journal ArticleAutophagy · January 2021
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been ...
Full textCite
Journal ArticleComput Struct Biotechnol J · 2021
Epithelial-mesenchymal plasticity plays a critical role in many solid tumor types as a mediator of metastatic dissemination and treatment resistance. In addition, there is also a growing appreciation that the epithelial/mesenchymal status of a tumor plays ...
Full textLink to itemCite
Journal ArticleFrontiers in oncology · January 2021
Metastasis is a multistep process in which cells must detach, migrate/invade local structures, intravasate, circulate, extravasate, and colonize. A full understanding of the complexity of this process has been limited by the lack of ability to study these ...
Full textCite
Journal ArticleEvol Med Public Health · 2021
BACKGROUND AND OBJECTIVES: Ischemic events, such as ischemic heart disease and stroke, are the number one cause of death globally. Ischemia prevents blood, carrying essential nutrients and oxygen, from reaching tissues, leading to cell and tissue death, an ...
Full textLink to itemCite
Journal ArticleMol Cancer Ther · December 2020
Colorectal cancer is the third most common cancer in the United States and responsible for over 50,000 deaths each year. Therapeutic options for advanced colorectal cancer are limited, and there remains an unmet clinical need to identify new treatments for ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · November 11, 2020
BACKGROUND: Osteosarcoma is a rare but aggressive bone cancer that occurs primarily in children. Like other rare cancers, treatment advances for osteosarcoma have stagnated, with little improvement in survival for the past several decades. Developing new t ...
Full textLink to itemCite
Journal ArticleEnviron Int · November 2020
As plastic waste accumulates in the ocean at alarming rates, the need for efficient and sustainable remediation solutions is urgent. One solution is the development and mobilization of technologies that either 1)prevent plastics from entering waterways or2 ...
Full textLink to itemCite
Journal ArticleBMC Cancer · October 14, 2020
BACKGROUND: Historically, amputation was the primary surgical treatment for osteosarcoma of the extremities; however, with advancements in surgical techniques and chemotherapies limb salvage has replaced amputation as the dominant treatment paradigm. This ...
Full textLink to itemCite
Journal ArticleMol Cancer Ther · July 2020
Therapeutic advances for osteosarcoma have stagnated over the past several decades, leading to an unmet clinical need for patients. The purpose of this study was to develop a novel therapy for osteosarcoma by reformulating and validating niclosamide, an es ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Cancer · June 24, 2020
BACKGROUND: Metastatic colorectal cancer (CRC) continues to be a major health problem, and current treatments are primarily for disease control and palliation of symptoms. In this study, we developed a precision medicine strategy to discover novel therapeu ...
Full textLink to itemCite
Journal ArticleGenes Chromosomes Cancer · April 2020
Circulating tumor cell (CTC) and cell-free (cf) DNA-based genomic alterations are increasingly being used for clinical decision-making in oncology. However, the concordance and discordance between paired CTC and cfDNA genomic profiles remain largely unknow ...
Full textLink to itemCite
Journal ArticleVet Comp Oncol · March 2020
Since William Coley utilized bacterial immunotherapy to treat sarcomas in the late 19th century, an association between infection and improved survival has been reported for human and canine osteosarcoma patients. One of the reasons for this improved survi ...
Full textLink to itemCite
Journal ArticleGenome Biol Evol · March 1, 2020
It has long been challenging to uncover the molecular mechanisms behind striking morphological innovations such as mammalian pregnancy. We studied the power of a robust comparative orthology pipeline based on gene synteny to address such problems. We infer ...
Full textLink to itemCite
Journal ArticleMol Biol Evol · February 1, 2020
Cancer progression is an evolutionary process. During this process, evolving cancer cell populations encounter restrictive ecological niches within the body, such as the primary tumor, circulatory system, and diverse metastatic sites. Efforts to prevent or ...
Full textLink to itemCite
Journal ArticleMol Biol Evol · January 1, 2020
Despite a considerable expenditure of time and resources and significant advances in experimental models of disease, cancer research continues to suffer from extremely low success rates in translating preclinical discoveries into clinical practice. The con ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2020
Cancer drug discovery is an inefficient process, with more than 90% of newly-discovered therapies failing to gain regulatory approval. Patient-derived models of cancer offer a promising new approach to identify new treatments; however, for rare cancers, su ...
Full textLink to itemCite
Chapter · January 1, 2020
In the United States alone prostate cancer is responsible for nearly 70 days each day. The vast majority of these deaths are due to metastatic spread of therapy-resistant disease. Metastasis and therapy resistance are mediated by phenotypic plasticity in w ...
Full textCite
Journal ArticleNucleic Acids Res · November 4, 2019
Enzalutamide, a second-generation androgen receptor (AR) antagonist, has demonstrated clinical benefit in men with prostate cancer. However, it only provides a temporary response and modest increase in survival, indicating a rapid evolution of resistance. ...
Full textOpen AccessLink to itemCite
Journal ArticleFrontiers in Marine Science · October 11, 2019
Plastic waste has reached epidemic proportions worldwide, and the production of plastic continues to rise steadily. Plastic represents a diverse array of commonly used synthetic polymers that are extremely useful as durable, economically beneficial alterna ...
Full textCite
Journal ArticleMol Cancer Res · June 2019
CDH1 (also known as E-cadherin), an epithelial-specific cell-cell adhesion molecule, plays multiple roles in maintaining adherens junctions, regulating migration and invasion, and mediating intracellular signaling. Downregulation of E-cadherin is a hallmar ...
Full textLink to itemCite
Journal ArticleEur J Hum Genet · May 2019
In the present study, 87 unrelated individuals from the Marquesas Archipelago in French Polynesia were typed using mtDNA, Y-chromosome and autosomal (STRs) markers and compared to key target populations from Island South East Asia (ISEA), Taiwan, and West ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 1, 2019
PURPOSE: Androgen receptor splice variant 7 (AR-V7) results in a truncated receptor, which leads to ligand-independent constitutive activation that is not inhibited by anti-androgen therapies, including abiraterone or enzalutamide. Given that previous repo ...
Full textLink to itemCite
Journal ArticleClin Orthop Relat Res · April 2019
BACKGROUND: For many cancer types, survival is improved when patients receive management at treatment centers that encounter high numbers of patients annually. This correlation may be more important with less common malignancies such as sarcoma. Existing e ...
Full textLink to itemCite
Journal ArticleJ Clin Med · February 7, 2019
The evolution of therapeutic resistance is a major cause of death for cancer patients. The development of therapy resistance is shaped by the ecological dynamics within the tumor microenvironment and the selective pressure of the host immune system. These ...
Full textLink to itemCite
Journal ArticlePharmacol Ther · February 2019
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and account for nearly all cancer-related deaths. Both metastasis and therapy resistance are fueled by epithelial plasticity, the reversible phenotypic transitions between ...
Full textLink to itemCite
Journal ArticlePLoS One · 2019
BACKGROUND: Radium-223 is a targeted alpha-particle therapy that improves survival in men with metastatic castration resistant prostate cancer (mCRPC), particularly in men with elevated serum levels of bone alkaline phosphatase (B-ALP). We hypothesized tha ...
Full textLink to itemCite
Journal ArticleCancer Res · November 15, 2017
Metastasis is a significant contributor to morbidity and mortality for many cancer patients and remains a major obstacle for effective treatment. In many tissue types, metastasis is fueled by the epithelial-to-mesenchymal transition (EMT)-a dynamic process ...
Full textLink to itemCite
Journal ArticleMol Oncol · July 2017
Phenotypic plasticity, the ability of cells to reversibly alter their phenotypes in response to signals, presents a significant clinical challenge to treating solid tumors. Tumor cells utilize phenotypic plasticity to evade therapies, metastasize, and colo ...
Full textLink to itemCite
Journal ArticleMol Oncol · July 2017
Epithelial-to-mesenchymal transition (EMT) and its reverse mesenchymal-to-epithelial transition (MET) have been suggested to play crucial roles in metastatic dissemination of carcinomas. These phenotypic transitions between states are not binary. Instead, ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · April 7, 2017
Phenotypic plasticity refers to a phenomenon in which cells transiently gain traits of another lineage. During carcinoma progression, phenotypic plasticity drives invasion, dissemination and metastasis. Indeed, while most of the studies of phenotypic plast ...
Full textLink to itemCite
Journal ArticleBiochim Biophys Acta Rev Cancer · April 2017
Despite decades of research and an enormity of resultant data, cancer remains a significant public health problem. New tools and fresh perspectives are needed to obtain fundamental insights, to develop better prognostic and predictive tools, and to identif ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 1, 2017
Purpose: Beyond enumeration, circulating tumor cells (CTCs) can provide genetic information from metastatic cancer that may facilitate a greater understanding of tumor biology and enable a precision medicine approach.Experimental Design: CTCs and paired le ...
Full textLink to itemCite
Journal ArticleMol Cell Biol · October 1, 2016
Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). I ...
Full textOpen AccessLink to itemCite
Journal ArticleOncogene · August 18, 2016
The cascade that culminates in macrometastases is thought to be mediated by phenotypic plasticity, including epithelial-mesenchymal and mesenchymal-epithelial transitions (EMT and MET). Although there is substantial support for the role of EMT in driving c ...
Full textOpen AccessLink to itemCite
Journal ArticleOncotarget · August 2, 2016
Treatment with androgen-targeted therapies can induce upregulation of epithelial plasticity pathways. Epithelial plasticity is known to be important for metastatic dissemination and therapeutic resistance. The goal of this study is to elucidate the functio ...
Full textOpen AccessLink to itemCite
Journal ArticleHistol Histopathol · June 2015
Carcinosarcomas are rare, biphasic tumors that are comprised of carcinomatous and sarcomatous elements. While the exact mechanism by which these two phenotypes arise within a single tumor remains unclear, molecular evidence indicates that the epitheliod an ...
Full textLink to itemCite
Journal ArticleMol Cell Biol · September 15, 2014
Metastatic dissemination requires carcinoma cells to detach from the primary tumor and invade through the basement membrane. To acquire these characteristics, epithelial tumor cells undergo epithelial-to-mesenchymal transitions (EMT), whereby cells lose po ...
Full textLink to itemCite
Journal ArticleCancer Metastasis Rev · September 2014
Nearly 30,000 men die annually in the USA of prostate cancer, nearly uniformly from metastatic dissemination. Despite recent advances in hormonal, immunologic, bone-targeted, and cytotoxic chemotherapies, treatment resistance and further dissemination are ...
Full textLink to itemCite
Journal ArticleGene · April 25, 2014
The U1 small nuclear (sn)RNA participates in splicing of pre-mRNAs by recognizing and binding to 5' splice sites at exon/intron boundaries. U1 snRNAs associate with 5' splice sites in the form of ribonucleoprotein particles (snRNPs) that are comprised of t ...
Full textLink to itemCite
Journal ArticleLupus · November 2013
OBJECTIVE: The objective of this paper is to determine whether patients with systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) possess differential IgM- and IgG-specific reactivity against peptides from the U1 small nuclear ribo ...
Full textLink to itemCite
Journal ArticleRNA · January 2013
Alternative splicing generates a vast diversity of protein isoforms from a limited number of protein-coding genes, with many of the isoforms possessing unique, and even contrasting, functions. Fluorescence-based splicing reporters have the potential to fac ...
Full textLink to itemCite
Journal ArticleLupus · March 2011
Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are autoimmune illnesses characterized by the presence of high titers of autoantibodies directed against a wide range of 'self ' antigens. Proteins of the U1 small nuclear ribonu ...
Full textLink to itemCite
Journal ArticleArch Insect Biochem Physiol · December 2010
Pre-messenger RNA splicing is a highly conserved eukaryotic cellular function that takes place by way of a large, RNA-protein assembly known as the spliceosome. In the mammalian system, nearly 300 proteins associate with uridine-rich small nuclear (sn)RNAs ...
Full textLink to itemCite
Journal ArticleRNA Biol · 2010
Alternative splicing is a general mechanism for regulating gene expression that affects the RNA products of more than 90% of human genes. Not surprisingly, alternative splicing is observed among gene products of metazoan immune systems, which have evolved ...
Full textOpen AccessLink to itemCite
Journal ArticleBiol Rev Camb Philos Soc · May 2009
Neanderthals represent an extinct hominid lineage that existed in Europe and Asia for nearly 400,000 years. They thrived in these regions for much of this time, but declined in numbers and went extinct around 30,000 years ago. Interestingly, their disappea ...
Full textLink to itemCite
Journal ArticleEntomological Research · March 1, 2009
In this study, five U2 small nuclear (sn)RNA variants were detected in the posterior silk gland of the Bombyx mori Nistari strain, one of which represents a novel U2 isoform not previously identified in other strains of this species. Following glycerol gra ...
Full textCite
Journal ArticleFEBS Lett · July 9, 2008
The spliceosome is a dynamic, macromolecular complex, which removes non-protein-coding introns from pre-mRNA to form mature mRNA in a process known as splicing. This ribonucleoprotein assembly is comprised of five uridine-rich small nuclear RNAs (snRNAs) a ...
Full textLink to itemCite
Journal ArticleProteins · July 2008
The FK506-binding proteins (FKBPs) are a unique group of chaperones found in a wide variety of organisms. They perform a number of cellular functions including protein folding, regulation of cytokines, transport of steroid receptor complexes, nucleic acid ...
Full textLink to itemCite
Journal ArticleEntomological Research · March 1, 2008
The spliceosome is a high molecular weight cellular complex responsible for the removal of non-protein coding introns from pre-mRNA to form mature mRNA transcripts. It comprises five major uridine (U)-rich small nuclear (sn)RNAs, to which a number of prote ...
Full textCite
Journal ArticleArch Insect Biochem Physiol · August 2007
The FK506-binding proteins (FKBPs) perform an extensive variety of functions in numerous organisms from archaea to humans. The FKBPs are distinguished by their peptidyl-prolyl cis-trans isomerase (PPIase) activity and ability to bind the immunosuppressive ...
Full textLink to itemCite
Journal ArticleBiol Cell · June 2007
BACKGROUND INFORMATION: The FKBPs (FK506-binding proteins) belong to a ubiquitous family of proteins that are found in a wide range of taxonomic groups. These proteins participate in a variety of pathways, including protein folding, down-regulation of T-ce ...
Full textLink to itemCite
Journal ArticleJ Environ Manage · January 2007
The presence of Escherichia coli in recreational and potable waters is a major concern to the general public as elevated levels of E. coli suggest the presence of pathogenic bacteria and viruses. Unfortunately, traditional microbial techniques do not allow ...
Full textLink to itemCite